OverviewPrevious problems with drug discovery led to considerable investment by the pharmaceutical industry into combinatorial and discovery chemistry. This conference will integrate the latest structural chemistry with innovative discovery-driven technologies. Taking place in Munich for the second year running, speakers will concentrate on the most important aspects of discovery stages for effective drug design and refinement. In the current economic climate there is increasing global competitiveness and financial pressure, therefore this conference aims to explore the options available to maximise the success of drug discovery and development. Our speakers have collaborated to provide four accessible tracks: - Fragment Based Lead Discovery
- Targeting Protein-protein Interactions
- Formulation & Solubility
- Chemical Biology
The tracks offered work synergistically to overcome the challenges of drug delivery in a completely new way. Select Biosciences hope to help delegates convert this expensive, challenging and inefficient process into a more accessible and affordable one.
Agenda and Information for:
|
|
|
Exhibition Sponsors
|
Media Sponsors
|
|
Networking
|
|
|
|
|
|